Literature DB >> 16876311

Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax).

F Javier de la Torre1, Angel García, Antonio Gil-Moreno, Jesus Planaguma, Jaume Reventos, Santiago Ramón y Cajal, Jordi Xercavins.   

Abstract

OBJECTIVE: The objective was to establish the importance of apoptosis-related genes and the apoptotic index (AI) as prognostic factors in patients with epithelial ovarian tumours.
MATERIAL AND METHODS: Tumour specimens from 130 epithelial ovarian tumours were examined for expression of p53, bcl-2 and bax proteins. The apoptotic index was evaluated by modified terminal deoxynucleotide-transferase-mediated digoxigenin triphosphate-biotin nick end-labelling (TUNEL) methods and by haematoxylin-eosin (H-E) staining. Other clinical and histopathological variables were also analysed. Statistical analyses were performed using the SPSS 10.0 package.
RESULTS: The apoptotic index detected by H-E and enzymatic assay was high in the majority of carcinomas (serous, endometrioid and clear cell (p=0.001). In the univariate survival analysis, high apoptotic index, high p53 and low bcl-2 expression, significantly correlated with shorter survival and shorter disease-free periods (p<0.01). In multivariate analysis the age (p=0.026; CI: 1.035-1.066 and p=0.011; CI: 1.835-2.077), FIGO stage (p=0.017; CI: 1.385-4.514 and p=0.024; CI: 1.217-1.940), p53 expression (p=0.03; CI: 1.017-1.627 and p=0.02; CI: 1.050-2.350) and apoptotic index (p=0.019; CI: 1.375-1.750 and p=0.019; CI: 1.442-2.085) were revealed to be independent prognostic factors for survival and recurrence, respectively.
CONCLUSIONS: Our results indicate that the apoptotic index and p53 nuclear accumulation are independent predictive factors of recurrence and short survival. Our data also suggest different patterns of alterations for the various tumour types.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876311     DOI: 10.1016/j.ejogrb.2005.11.048

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Mechanism of the promotion of steatotic HepG2 cell apoptosis by cholesterol.

Authors:  Chunyan Zhu; Ping Xie; Fei Zhao; Lingqiang Zhang; Wei An; Yutao Zhan
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.

Authors:  Prakash Vishnu; Gerardo Colon-Otero; Gregory T Kennedy; Laura A Marlow; William P Kennedy; Kevin J Wu; Joseph T Santoso; John A Copland
Journal:  Gynecol Oncol       Date:  2011-11-22       Impact factor: 5.482

3.  Downregulation of KLF4 and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer.

Authors:  Ok Yoon; Jaesook Roh
Journal:  Oncol Lett       Date:  2012-07-30       Impact factor: 2.967

Review 4.  The biology of ovarian cancer: new opportunities for translation.

Authors:  Robert C Bast; Bryan Hennessy; Gordon B Mills
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

5.  Long non-coding RNA FLJ33360 participates in ovarian cancer progression by sponging miR-30b-3p.

Authors:  Meiqin Yang; Zhensheng Zhai; Shuang Guo; Xiaoxi Li; Yongxia Zhu; Yue Wang
Journal:  Onco Targets Ther       Date:  2019-06-07       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.